Fact CheckerSign in

NCT06311149Recruiting

Multicenter Evaluation of Patients Using LATITUDE Monitoring System

Multicenter Evaluation of Patients Using LATITUDE Monitoring System: Multitude Study

Source: ClinicalTrials.gov · Last updated 12 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database. The registry is designed to constitute a shared environment for the collection, management, analysis and reporting of clinical and diagnostic data, adopted by a network of European scientifically-motivated physicians who use rhythm management diagnostic and therapeutic solutions from Boston Scientific in their clinical practice. The Multitude study will facilitate the sharing of scientific proposals within a large network of researchers, and it will allow researchers to record the experience with medical devices throughout the device and patient lifecycle.

Status (registry)
Recruiting
Study type
Observational
Enrollment
20000 (estimated)
First submitted
7 Mar 2024
Start date
1 Dec 2023
Primary completion date
31 Dec 2043
Lead sponsor
University Hospital of Ferrara
NCT number
NCT06311149

What you commit to

  • Study type: Observational
  • Planned participants: 20000
  • From 1 Dec 2023 to the primary completion date, 31 Dec 2043
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subject foreseen not to be followed at the enrolling center for at least 1 year after having received the device.
  • Subject is receiving a device that is not approved for commercial use at the time of procedure.

Who the study is looking for

  • Subject is willing and capable of providing informed consent to collect/store/process personal health information by the sponsor or such consent is provided by a legally designated representative, if required by local law or regulation.
  • Subject is:
    • prospectively scheduled for receiving a device monitored through the LATITUDE monitoring system
    • retrospectively enrolled after having received a device monitored through the LATITUDE monitoring system

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Azienda Ospedaliero Universitaria di Ferrara
Coordinator of this site? Confirm its status
FerraraItalyRecruiting
Policlinico Federico II
Coordinator of this site? Confirm its status
NaplesItalyRecruiting
Ospedale "G.B. Grassi"
Coordinator of this site? Confirm its status
RomaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.